ClearTrial to Present Best Practices in Resource Forecasting at CHI's Summit for Clinical Operations Executives (SCOPE) Conference

ClearTrial (http://www.cleartrial.com), the leading provider of software for the planning, forecasting, and tracking of clinical project and financial performance, announced today that Molly Blake-Michaels, Senior Director, Clinical Services for ClearTrial, has been asked to present at Cambridge Healthtech Institute's (CHI) Summit for Clinical Operations Executives (SCOPE) Conference. Attended each year by more than 350 key biopharmaceutical and medical device executives, SCOPE features best practice case studies and interactive discussions relevant to experts in clinical development, clinical operations, outsourcing, and project management.

Blake-Michaels will present “Effective Resource Planning: Reducing Clinical Project Risk and Cost” in the conference's Clinical Trial Forecasting, Budgeting, and Project Management track. Her presentation will explore the challenges facing biopharmaceutical and medical device companies in accurately planning resource demand, leading to increased project risk and higher development costs. Blake-Michaels will also provide case studies of how leading sponsors are overcoming these challenges to allocate resources efficiently for individual studies as well as across the project portfolio—reducing project risk, lowering operating costs, and improving employee morale and productivity.

Conference organizers have also called upon Blake-Michaels to moderate a roundtable discussion, "Effectively Managing Resources: Driving Strategic Clinical Resource Planning and Capacity Management.” This roundtable will address questions critical to improving study efficiency and outcomes, including:

• How are leading study sponsors forecasting and managing resources more effectively?
• What benefits are they seeing from doing so?
• What are some of the challenges (e.g., organizational, cultural, technological) facing efforts to implement these best practices?

"ClearTrial is honored to have been invited by Cambridge Healthtech Institute to share our thought leadership and domain expertise at this important industry conference," noted Andrew Grygiel, Chief Marketing Officer for ClearTrial. "We look forward to helping life sciences companies compress study cycle-times and reduce study cost and risk through effective resource planning.”

The CHI SCOPE conference is being held February 7-9, 2012 at the Hilton Miami Downtown in Miami, Florida. For more information or to register, visit http://www.scopesummit.com/.

About ClearTrial®

ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, linking clinical planning, forecasting, and tracking of operational and financial performance in a single, integrated system. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

Connect with ClearTrial:

Twitter

LinkedIn

YouTube